Landscape of protein-protein interactions during hepatitis C virus assembly and release

Alina Matthaei,Sebastian Joecks,Annika Frauenstein,Janina Bruening,Dorothea Bankwitz,Martina Friesland,Gisa Gerold,Gabrielle Vieyres,Lars Kaderali,Felix Meissner,Thomas Pietschmann

DOI: https://doi.org/10.1128/spectrum.02562-22

IF: 3.7

2024-01-18

Microbiology Spectrum

Abstract:ABSTRACT Assembly of infectious hepatitis C virus (HCV) particles requires multiple cellular proteins including for instance apolipoprotein E (ApoE). To describe these protein-protein interactions, we performed an affinity purification mass spectrometry screen of HCV-infected cells. We used functional viral constructs with epitope-tagged envelope protein 2 (E2), protein (p) 7, or nonstructural protein 4B (NS4B) as well as cells expressing a tagged variant of ApoE. We also evaluated assembly stage-dependent remodeling of protein complexes by using viral mutants carrying point mutations abrogating particle production at distinct steps of the HCV particle production cascade. Five ApoE binding proteins, 12 p7 binders, 7 primary E2 interactors, and 24 proteins interacting with NS4B were detected. Cell-derived PREB, STT3B, and SPCS2 as well as viral NS2 interacted with both p7 and E2. Only GTF3C3 interacted with E2 and NS4B, highlighting that HCV assembly and replication complexes exhibit largely distinct interactomes. An HCV core protein mutation, preventing core protein decoration of lipid droplets, profoundly altered the E2 interactome. In cells replicating this mutant, E2 interactions with HSPA5, STT3A/B, RAD23A/B, and ZNF860 were significantly enhanced, suggesting that E2 protein interactions partly depend on core protein functions. Bioinformatic and functional studies including STRING network analyses, RNA interference, and ectopic expression support a role of Rad23A and Rad23B in facilitating HCV infectious virus production. Both Rad23A and Rad23B are involved in the endoplasmic reticulum (ER)-associated protein degradation (ERAD). Collectively, our results provide a map of host proteins interacting with HCV assembly proteins, and they give evidence for the involvement of ER protein folding machineries and the ERAD pathway in the late stages of the HCV replication cycle. IMPORTANCE Hepatitis C virus (HCV) establishes chronic infections in the majority of exposed individuals. This capacity likely depends on viral immune evasion strategies. One feature likely contributing to persistence is the formation of so-called lipo-viro particles. These peculiar virions consist of viral structural proteins and cellular lipids and lipoproteins, the latter of which aid in viral attachment and cell entry and likely antibody escape. To learn about how lipo-viro particles are coined, here, we provide a comprehensive overview of protein-protein interactions in virus-producing cells. We identify numerous novel and specific HCV E2, p7, and cellular apolipoprotein E-interacting proteins. Pathway analyses of these interactors show that proteins participating in processes such as endoplasmic reticulum (ER) protein folding, ER-associated protein degradation, and glycosylation are heavily engaged in virus production. Moreover, we find that the proteome of HCV replication sites is distinct from the assembly proteome, suggesting that transport process likely shuttles viral RNA to assembly sites.

microbiology

What problem does this paper attempt to address?

The paper primarily explores the protein interaction network involved in the assembly and release of the Hepatitis C Virus (HCV). Specifically, the researchers identified proteins interacting with key viral proteins in HCV-infected cells (including envelope protein 2 (E2), protein 7 (p7), and non-structural protein 4B (NS4B)) as well as apolipoprotein E (ApoE) in host cells through Affinity Purification Mass Spectrometry (AP-MS).

Key findings of the study include:

1. **Protein Interaction Network**: Multiple host proteins interacting with HCV E2, p7, NS4B, and ApoE were identified. These interactions revealed the composition of different protein complexes involved in HCV particle assembly.

2. **Assembly Stage-Dependent Reconstitution**: By analyzing viral strains carrying specific mutations that affect different stages of HCV particle production, the researchers assessed changes in protein complexes during the assembly process.

3. **Discovery of New Interactions**: Several novel proteins interacting with HCV E2, p7, and host ApoE were discovered, aiding in the understanding of how HCV particles form.

4. **Pathway Analysis**: Bioinformatics analysis of these interactions showed that proteins involved in endoplasmic reticulum (ER) protein folding, ER-associated degradation (ERAD) pathways, and glycosylation play important roles in viral production.

5. **Impact of Core Protein Mutations**: An HCV core protein mutation that prevents core protein modification of lipid droplets significantly altered the interaction network of E2. This indicates that E2 interactions are partially dependent on core protein function.

6. **Functional Validation**: Further support for the roles of Rad23A and Rad23B in promoting the production of infectious HCV was provided through RNA interference and ectopic expression experiments.

In summary, this study provides a map of host proteins interacting with HCV assembly proteins and offers evidence for the involvement of ER protein folding mechanisms and the ERAD pathway in the late stages of the HCV replication cycle. These findings are significant for understanding the HCV assembly process and its interactions with host cells.